Aleniglipron
A Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants
Gasherbrum Bio, Inc · Phase 1 · Status n/r · Enrollment 70
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.